344 related articles for article (PubMed ID: 14613994)
1. Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increases their sensitivity to antiangiogenic therapy.
Muramaki M; Miyake H; Hara I; Kamidono S
Clin Cancer Res; 2003 Nov; 9(14):5152-60. PubMed ID: 14613994
[TBL] [Abstract][Full Text] [Related]
2. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts.
Lund EL; Bastholm L; Kristjansen PE
Clin Cancer Res; 2000 Mar; 6(3):971-8. PubMed ID: 10741723
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma.
Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
Clin Cancer Res; 2003 Feb; 9(2):886-99. PubMed ID: 12576464
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y
Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.
Hotz HG; Reber HA; Hotz B; Sanghavi PC; Yu T; Foitzik T; Buhr HJ; Hines OJ
J Gastrointest Surg; 2001; 5(2):131-8. PubMed ID: 11331474
[TBL] [Abstract][Full Text] [Related]
7. In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin.
Tanaka M; Grossman HB
Gene Ther; 2003 Sep; 10(19):1636-42. PubMed ID: 12923562
[TBL] [Abstract][Full Text] [Related]
8. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.
Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML
Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568
[TBL] [Abstract][Full Text] [Related]
9. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8.
Karashima T; Sweeney P; Kamat A; Huang S; Kim SJ; Bar-Eli M; McConkey DJ; Dinney CP
Clin Cancer Res; 2003 Jul; 9(7):2786-97. PubMed ID: 12855659
[TBL] [Abstract][Full Text] [Related]
11. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis.
Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K
Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
[TBL] [Abstract][Full Text] [Related]
13. Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth.
Ceci C; Tentori L; Atzori MG; Lacal PM; Bonanno E; Scimeca M; Cicconi R; Mattei M; de Martino MG; Vespasiani G; Miano R; Graziani G
Nutrients; 2016 Nov; 8(11):. PubMed ID: 27879653
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic therapy inhibits human neuroblastoma growth.
Katzenstein HM; Salwen HR; Nguyen NN; Meitar D; Cohn SL
Med Pediatr Oncol; 2001 Jan; 36(1):190-3. PubMed ID: 11464880
[TBL] [Abstract][Full Text] [Related]
15. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers.
O'Brien T; Cranston D; Fuggle S; Bicknell R; Harris AL
Cancer Res; 1996 Jun; 56(11):2515-8. PubMed ID: 8653688
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effects of TNP-470 in combination with 5-fluorouracil on growth of human colon cancer].
Fan YF; Huang ZH; Nie J
Ai Zheng; 2002 Dec; 21(12):1319-23. PubMed ID: 12520739
[TBL] [Abstract][Full Text] [Related]
17. Effect of nitroxoline on angiogenesis and growth of human bladder cancer.
Shim JS; Matsui Y; Bhat S; Nacev BA; Xu J; Bhang HE; Dhara S; Han KC; Chong CR; Pomper MG; So A; Liu JO
J Natl Cancer Inst; 2010 Dec; 102(24):1855-73. PubMed ID: 21088277
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
[TBL] [Abstract][Full Text] [Related]
20. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis.
Choudhuri R; Zhang HT; Donnini S; Ziche M; Bicknell R
Cancer Res; 1997 May; 57(9):1814-9. PubMed ID: 9135027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
